SamanTree Medical
Latest round
- Series B
Last raised
- Apr 2025
Total raised
- $43M
Investors
- 10
About SamanTree Medical
Based in Switzerland, founded in 2014 by Olivier Delporte and headquartered in Lausanne, Switzerland, SamanTree Medical SA specializes in advanced imaging technology that provides real-time tissue assessment for surgical applications, enhancing decision-making in critical healthcare settings. SamanTree Medical SA, founded in 2014 and headquartered in Lausanne, Switzerland, focuses on innovative medical imaging solutions. CEO Olivier Delporte oversees the company's strategic direction. SamanTree Medical specializes in advanced imaging technology for real-time tissue assessment in surgical settings. Their flagship product, the Histolog® Scanner, employs ultra-fast confocal microscopy technology for high-resolution imaging of fresh human tissue specimens. By enabling clinicians to visualize morphological microstructures, the Histolog Scanner supports immediate decision-making at the point of care, addressing critical challenges in cancer diagnosis and treatment. The device facilitates swift scanning of resected tissue samples, providing easy-to-read images in under a minute, which enhances the efficiency of tissue assessment processes.SamanTree Medical generates revenue through the sale of its innovative imaging solutions, particularly the Histolog® Scanner, which has received CE marking and FDA clearance. The company engages in direct sales to healthcare institutions and collaborates with medical professionals in surgical environments. Revenue transactions typically involve one-time purchases of the Histolog Scanner and related products, such as the Histolog Dip and Histolog Dish. Additionally, the company may establish partnerships with medical facilities to provide ongoing support, training, and software solutions, ensuring clients can effectively utilize the imaging technology in their procedures. This comprehensive approach facilitates a robust business model focused on delivering value to clinicians and improving patient outcomes in cancer care.
Who invested in SamanTree Medical
10 investors across 3 rounds
See all investors in SamanTree Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SamanTree Medical
Who invested in SamanTree Medical?
SamanTree Medical has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SamanTree Medical raised?
SamanTree Medical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SamanTree Medical last raise money?
SamanTree Medical's most recent round on record is a Series B, in Apr 2025.
What does SamanTree Medical do?
Based in Switzerland, founded in 2014 by Olivier Delporte and headquartered in Lausanne, Switzerland, SamanTree Medical SA specializes in advanced imaging technology that provides real-time tissue assessment for surgical applications, enhancing decision-making in critical healthcare settings.
Where is SamanTree Medical headquartered?
SamanTree Medical is headquartered in Belgium.
Which VCs invest in companies like SamanTree Medical?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at SamanTree Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like SamanTree Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.